RecruitingACTRN12625000200482

Assessing the effectiveness of Hospital-Based Manufactured Medical Device Restorabite for treatment of Trismus in adults after head and neck cancer surgery (Cohort 2)

Efficacy of Hospital-Based Manufactured Medical Device Restorabite for treatment of Trismus in adults after head and neck cancer surgery (Cohort 2).


Sponsor

Chris O'Brien Lifehouse

Enrollment

280 participants

Start Date

Apr 14, 2023

Study Type

Interventional

Conditions

Summary

This study aims to assess the efficacy of a "Restorabite" device to treat a disorder called trismus in head and neck cancer patients. Who is it for? You may be eligible for this study if you are an adult with, or who has had in the past, head and neck cancer, and has trouble opening your jaw wider than 35mm. Study details Patients will attend 10 x 1 hour weekly sessions with a speech pathologist, where they will be taken through passive and active jaw range of motion exercises. They will also be instructed to complete 20 minutes of home practice daily over the 10-week study period. Data on changes in jaw opening distance and quality of life will be collected. It is hoped that findings in this study help researchers determine optimal stretching regime for trismus treatment. Participation in this clinical trial is voluntary.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

Trismus is a condition where the jaw cannot open fully — it is a common and distressing side effect for people who have had surgery or radiation therapy for head and neck cancers. When the jaw can only open 35mm or less, it can affect eating, speaking, and quality of life significantly. There are few well-studied treatments available. This study is testing a custom-made jaw-stretching device called Restorabite, which patients use alongside a structured program of jaw exercises guided by a speech pathologist. Participants attend 10 weekly one-hour sessions and also do 20 minutes of home exercises each day. Changes in jaw opening distance and quality of life will be measured before and after the 10-week program. You may be eligible if you are 18 or older, have been diagnosed with head and neck cancer, and are unable to open your mouth wider than 35mm. This study is voluntary and may help researchers develop the best possible exercise approach for people dealing with trismus after head and neck cancer treatment.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The primary objective is to determine optimal exercise duration and force to treat Trismus. Description of Interventions: • Passive jaw range of motion exercises using Restorabite as per randomise

The primary objective is to determine optimal exercise duration and force to treat Trismus. Description of Interventions: • Passive jaw range of motion exercises using Restorabite as per randomised Arm • Active jaw range of motion exercises using Restorabite as per randomised Arm • 10 x 1hr weekly sessions face to face or over telehealth with speech pathology. Gradual progression through the force hierarchy as clinically indicated. • Home practice: daily for 20 minutes for duration of study (10 weeks) Passive and active jaw range of motion exercises is a continuous exercise performed with Restorabite. It involves inserting the pressed down Restorabite between the front teeth and letting the device stretch the jaw (passive motion exercise) then bite down on the mouth guards (active motion exercise). Then repeat the letting go of the bite (passive motion exercise) and biting down on the device (active motion exercise). Participants will be given a Restorabite device and randomised to one of seven daily exercise programs (20 minutes daily). Arm 1. Low force for maximum of 30 seconds of 4 repetitions x 5 times with Restorabite Arm 2. Low force for maximum of 60 seconds of 2 repetitions x 5 times with Restorabite Arm 3. Low force for maximum of 120 seconds of 1 repetition x 5 times with Restorabite Arm 4. High force for maximum of 30 seconds of 4 repetitions x 5 times with Restorabite Arm 5. High force for maximum of 60 seconds of 2 repetitions x 5 times with Restorabite Arm 6. High force for maximum of 120 seconds of 1 repetition x 5 times with Restorabite Control. Stacked tongue depressor for maximum of 30 seconds of 5 repetitions x 5 times Low force is defined as maximum intensity of up to 30N (insert position 4 on Restorabite device) High force is defined as maximum intensity of up to 50N (insert position 8 on Restorabite device) Participants will be given a device, and the treatment will last for 10 weeks. Participants will be asked to attend 10 sessions of 1-hour weekly appointments with the speech pathologist. These appointments can be conducted either in person or via Telehealth. Follow up appointments will be required at 6 months and 12 months after the study treatment finishes. At the first and last appointments and 6 months and 12 months follow up appointments, participants will be asked to answer Quality of Life (QoL) questionnaires. Optional semi-structured interviews, using an interview guide, will be conducted with patients to evaluate their experiences using a device for trismus at the end of the intervention. These 30-60minute interviews will be conducted via video conferencing (Zoom) once during the course of the trial. To monitor adherence to the intervention speech pathologists will closely follow up participants. To increase the adherence to the intervention, speech pathologists will set up a 10-week appointment plan at the beginning of the trial and also offer tele-health appointments.


Locations(6)

Chris O’Brien Lifehouse - Camperdown

ACT,NSW,QLD,VIC, Australia

Peter MacCallum Cancer Centre - Melbourne

ACT,NSW,QLD,VIC, Australia

Royal Melbourne Hospital - City campus - Parkville

ACT,NSW,QLD,VIC, Australia

Westmead Private Hospital - Westmead

ACT,NSW,QLD,VIC, Australia

Wollongong Hospital - Wollongong

ACT,NSW,QLD,VIC, Australia

The Canberra Hospital - Garran

ACT,NSW,QLD,VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12625000200482


Related Trials